Michael Amylon

Publications

• Projective drawings as measures of psychosocial functioning in siblings of pediatric cancer patients from the Camp Okizu study. Packman W, Mazaheri M, Sporri L, Long JK, Chesterman B, Fine J, Amylon MD. J Pediatr Oncol Nurs. 2008 Jan-Feb; 25 (1): 44-55
• Safety of hematopoietic stem cell transplantation in children less than three years of age. Dvorak CC, Wright NB, Wong WB, Kristovich KM, Matthews EW, Weinberg KI, Amylon MD, Agarwal R. Pediatr Hematol Oncol. 2008; 25 (8): 705-22
• Hematopoietic stem cell transplantation after first marrow relapse of non-T, non-B acute lymphoblastic leukemia: a pediatric oncology group pilot feasibility study. Sandler ES, Homans A, Mandell L, Amylon M, Wall DA, Devidas M, Buchanan GR, Lipton JM, Billett AL. J Pediatr Hematol Oncol. 2006; 28 (4): 210-5
• Siblings of pediatric cancer patients: the quantitative and qualitative nature of quality of life. Packman W, Greenhalgh J, Chesterman B, Shaffer T, Fine J, Van Zutphen K, Golan R, Amylon MD. J Psychosoc Oncol. 2005; 23 (1): 87-108
• High-dose therapy and autologous hematopoietic stem-cell transplantation for recurrent or refractory pediatric Hodgkin's disease: results and prognostic indices. Lieskovsky YE, Donaldson SS, Torres MA, Wong RM, Amylon MD, Link MP, Agarwal R. J Clin Oncol. 2004; 22 (22): 4532-40
• Allogeneic hematopoietic cell transplantation for patients with high-risk acute lymphoblastic leukemia in first or second complete remission using fractionated total-body irradiation and high-dose etoposide: a 15-year experience. Jamieson CH, Amylon MD, Wong RM, Blume KG. Exp Hematol. 2003; 31 (10): 981-6
• Results of minimally toxic nonmyeloablative transplantation in patients with sickle cell anemia and beta-thalassemia. Iannone R, Casella JF, Fuchs EJ, Chen AR, Jones RJ, Woolfrey A, Amylon M, Sullivan KM, Storb RF, Walters MC. Biol Blood Marrow Transplant. 2003; 9 (8): 519-28
• High-dose therapy and autologous hematopoietic cell transplantation in children with primary refractory and relapsed Hodgkin's disease: atopy predicts idiopathic diffuse lung injury syndromes. Frankovich J, Donaldson SS, Lee Y, Wong RM, Amylon M, Verneris MR. Biol Blood Marrow Transplant. 2001; 7 (1): 49-57
• Equivalence of 2 effective graft-versus-host disease prophylaxis regimens: results of a prospective double-blind randomized trial. Chao NJ, Snyder DS, Jain M, Wong RM, Niland JC, Negrin RS, Long GD, Hu WW, Stockerl-Goldstein KE, Johnston LJ, Amylon MD, Tierney DK, O'Donnell MR, Nademanee AP, Parker P, Stein A, Molina A, Fung H, Kashyap A, Kohler S, Spielberger R, Krishnan A, Rodriguez R, Forman SJ, Bluzme KG. Biol Blood Marrow Transplant. 2000; 6 (3): 254-61
• Cyclosporine, methotrexate, and prednisone compared with cyclosporine and prednisone for prevention of acute graft-vs.-host disease: effect on chronic graft-vs.-host disease and long-term survival. Ross M, Schmidt GM, Niland JC, Amylon MD, Dagis AC, Long GD, Nademanee AP, Negrin RS, O'Donnell MR, Parker PM, Smith EP, Snyder DS, Stein AS, Wong RM, Forman SJ, Blume KG, Chao NJ. Biol Blood Marrow Transplant. 1999; 5 (5): 285-91
• Intensive high-dose asparaginase consolidation improves survival for pediatric patients with T cell acute lymphoblastic leukemia and advanced stage lymphoblastic lymphoma: a Pediatric Oncology Group study. Amylon MD, Shuster J, Pullen J, Berard C, Link MP, Wharam M, Katz J, Yu A, Laver J, Ravindranath Y, Kurtzberg J, Desai S, Camitta B, Murphy SB. Leukemia. 1999; 13 (3): 335-42
• Long-term follow-up of 23 patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with allogeneic bone marrow transplant in first complete remission. Snyder DS, Nademanee AP, O'Donnell MR, Parker PM, Stein AS, Margolin K, Somlo G, Molina A, Spielberger R, Kashyap A, Fung H, Slovak ML, Dagis A, Negrin RS, Amylon MD, Blume KG, Forman SJ. Leukemia. 1999; 13 (12): 2053-8
• Allogeneic bone marrow transplant in pediatric patients with high-risk hematopoietic malignancies early in the course of their disease. Amylon MD, Co JP, Snyder DS, Donaldson SS, Blume KG, Forman SJ. J Pediatr Hematol Oncol. 1997 Jan-Feb; 19 (1): 54-61
• Fractionated total-body irradiation, etoposide, and cyclophosphamide followed by allogeneic bone marrow transplantation for patients with high-risk or advanced-stage hematological malignancies. Long GD, Amylon MD, Stockerl-Goldstein KE, Negrin RS, Chao NJ, Hu WW, Nademanee AP, Snyder DS, Hoppe RT, Vora N, Wong R, Niland J, Reichardt VL, Forman SJ, Blume KG. Biol Blood Marrow Transplant. 1997; 3 (6): 324-30
• Antimetabolite-based therapy in childhood T-cell acute lymphoblastic leukemia: a report of POG study 9296. Winter SS, Holdsworth MT, Devidas M, Raisch DW, Chauvenet A, Ravindranath Y, Ducore JM, Amylon MD. Pediatr Blood Cancer. 2006; 46 (2): 179-86
• PharmGKB update: II. CYP3A5, cytochrome P450, family 3, subfamily A, polypeptide 5. Schuetz EG, Relling MV, Kishi S, Yang W, Das S, Chen P, Cook EH, Rosner GL, Pui CH, Blanco JG, Edick MJ, Hancock ML, Winick NJ, Dervieux T, Amylon MD, Bash RO, Behm FG, Camitta BM, Raimondi SC, Goh BC, Lee SC, Wang LZ, Fan L, Guo JY, Lamba J, Lim R, Lim HL, Ong AB, Lee HS, Kuehl P, Zhang J, Lin Y, Assem M, Schuetz J, Watkins PB, Daly A, Wrighton SA, Hall SD, Maurel P, Brimer C, Yasuda K, Venkataramanan R, Strom S, Thummel K, Boguski MS. Pharmacol Rev. 2004; 56 (2): 159
• Development and testing of the School Competency Assessment Scale. Challinor J, Moore IK, Kramer R, Pasvogel A, Leung K, Amylon M, Hutter J, Matthay K. J Pediatr Oncol Nurs. 2003 Mar-Apr; 20 (2): 56-64
• Bone marrow stroma-supported culture of T-lineage acute lymphoblastic leukemic cells predicts treatment outcome in children: a Pediatric Oncology Group study. Winter SS, Sweatman J, Shuster JJ, Link MP, Amylon MD, Pullen J, Camitta BM, Larson RS. Leukemia. 2002; 16 (6): 1121-6
• Genetic polymorphisms in CYP3A5, CYP3A4 and NQO1 in children who developed therapy-related myeloid malignancies. Blanco JG, Edick MJ, Hancock ML, Winick NJ, Dervieux T, Amylon MD, Bash RO, Behm FG, Camitta BM, Pui CH, Raimondi SC, Relling MV. Pharmacogenetics. 2002; 12 (8): 605-11
• Relationship of p15 and p16 gene alterations to elevated dihydrofolate reductase in childhood acute lymphoblastic leukaemia. Shah SJ, Taub JW, Witt TL, Pollock BH, Ding BC, Moore DS, Amylon M, Pullen J, Ravindranath Y, Matherly LH. Br J Haematol. 2001; 113 (3): 746-56
• Cost analysis of filgrastim for the prevention of neutropenia in pediatric T-cell leukemia and advanced lymphoblastic lymphoma: a case for prospective economic analysis in cooperative group trials. Bennett CL, Stinson TJ, Lane D, Amylon M, Land VJ, Laver JH. Med Pediatr Oncol. 2000; 34 (2): 92-6
• Effects of cranial radiation in children with high risk T cell acute lymphoblastic leukemia: a Pediatric Oncology Group report. Laver JH, Barredo JC, Amylon M, Schwenn M, Kurtzberg J, Camitta BM, Pullen J, Link MP, Borowitz M, Ravindranath Y, Murphy SB, Shuster J. Leukemia. 2000; 14 (3): 369-73
• Glutathione S-transferase genotypes in children who develop treatment-related acute myeloid malignancies. Woo MH, Shuster JJ, Chen C, Bash RO, Behm FG, Camitta B, Felix CA, Kamen BA, Pui CH, Raimondi SC, Winick NJ, Amylon MD, Relling MV. Leukemia. 2000; 14 (2): 232-7
• New recurring cytogenetic abnormalities and association of blast cell karyotypes with prognosis in childhood T-cell acute lymphoblastic leukemia: a pediatric oncology group report of 343 cases. Schneider NR, Carroll AJ, Shuster JJ, Pullen DJ, Link MP, Borowitz MJ, Camitta BM, Katz JA, Amylon MD. Blood. 2000; 96 (7): 2543-9
• Slow disappearance of peripheral blood blasts is an adverse prognostic factor in childhood T cell acute lymphoblastic leukemia: a Pediatric Oncology Group study. Griffin TC, Shuster JJ, Buchanan GR, Murphy SB, Camitta BM, Amylon MD. Leukemia. 2000; 14 (5): 792-5
• Comparison of two doses of intravenous immunoglobulin after allogeneic bone marrow transplants. Abdel-Mageed A, Graham-Pole J, Del Rosario ML, Longmate J, Ochoa S, Amylon M, Elfenbein GJ, Janiec J, Jansen J, Lazarus HM. Bone Marrow Transplant. 1999; 23 (9): 929-32
• Significance of commonly used prognostic factors differs for children with T cell acute lymphocytic leukemia (ALL), as compared to those with B-precursor ALL. A Pediatric Oncology Group (POG) study. Pullen J, Shuster JJ, Link M, Borowitz M, Amylon M, Carroll AJ, Land V, Look AT, McIntyre B, Camitta B. Leukemia. 1999; 13 (11): 1696-707
• Somatization, anxiety and depression as measures of health-related quality of life of children/adolescents with cancer. Challinor JM, Miaskowski CA, Franck LS, Slaughter RE, Matthay KK, Kramer RF, Veatch JJ, Paul SM, Amylon MD, Moore IM. Int J Cancer Suppl. 1999: 12 52-7
• Use of alanosine as a methylthioadenosine phosphorylase-selective therapy for T-cell acute lymphoblastic leukemia in vitro. Batova A, Diccianni MB, Omura-Minamisawa M, Yu J, Carrera CJ, Bridgeman LJ, Kung FH, Pullen J, Amylon MD, Yu AL. Cancer Res. 1999; 59 (7): 1492-7
• Bone marrow transplant in thalassemia. A role for radiation? Lee YS, Kristovich KM, Ducore JM, Vichinsky E, Crouse VL, Glader BE, Amylon MD. Ann N Y Acad Sci. 1998: 850 503-5
• Randomized trial of r-metHu granulocyte colony-stimulating factor in an intensive treatment for T-cell leukemia and advanced-stage lymphoblastic lymphoma of childhood: a Pediatric Oncology Group pilot study. Laver J, Amylon M, Desai S, Link M, Schwenn M, Mahmoud H, Shuster J. J Clin Oncol. 1998; 16 (2): 522-6
• Increased frequency of expression of elevated dihydrofolate reductase in T-cell versus B-precursor acute lymphoblastic leukemia in children. Matherly LH, Taub JW, Wong SC, Simpson PM, Ekizian R, Buck S, Williamson M, Amylon M, Pullen J, Camitta B, Ravindranath Y. Blood. 1997; 90 (2): 578-89
• Influence of age on the outcome of 500 autologous bone marrow transplant procedures for hematologic malignancies. Kusnierz-Glaz CR, Schlegel PG, Wong RM, Schriber JR, Chao NJ, Amylon MD, Hu WW, Negrin RS, Lee Y, Blume KG, Long GD. J Clin Oncol. 1997; 15 (1): 18-25
• Shortened survival after relapse in T-cell acute lymphoblastic leukemia patients with p16/p15 deletions. Diccianni MB, Batova A, Yu J, Vu T, Pullen J, Amylon M, Pollock BH, Yu AL. Leuk Res. 1997; 21 (6): 549-58
• Identifying early predictors of mortality in pediatric patients with acute leukemia and pneumonia. Randle CJ, Frankel LR, Amylon MD. Chest. 1996; 109 (2): 457-61
• Influence of preparatory regimen and source of hematopoietic cells on outcome of autotransplantation for non-Hodgkin's lymphoma. Stockerl-Goldstein KE, Horning SJ, Negrin RS, Chao NJ, Hu WW, Long GD, Hoppe RT, Amylon MD, Brown BW, Wong RM, Blume KG. Biol Blood Marrow Transplant. 1996; 2 (2): 76-85
• Pleuropulmonary blastoma: a marker for familial disease. Priest JR, Watterson J, Strong L, Huff V, Woods WG, Byrd RL, Friend SH, Newsham I, Amylon MD, Pappo A, Mahoney DH, Langston C, Heyn R, Kohut G, Freyer DR, Bostrom B, Richardson MS, Barredo J, Dehner LP. J Pediatr. 1996; 128 (2): 220-4
• Busulfan/cyclophosphamide as conditioning regimen for allogeneic bone marrow transplantation for myelodysplasia. O'Donnell MR, Long GD, Parker PM, Niland J, Nademanee A, Amylon M, Chao N, Negrin RS, Schmidt GM, Slovak ML. J Clin Oncol. 1995; 13 (12): 2973-9
• Does activation of the TAL1 gene occur in a majority of patients with T-cell acute lymphoblastic leukemia? A pediatric oncology group study. Bash RO, Hall S, Timmons CF, Crist WM, Amylon M, Smith RG, Baer R. Blood. 1995; 86 (2): 666-76
• Bone marrow transplantation for thalassemia. The USA experience. Walters MC, Sullivan KM, O'Reilly RJ, Boulad F, Brockstein J, Blume K, Amylon M, Johnson FL, Klemperer M, Graham-Pole J. Am J Pediatr Hematol Oncol. 1994; 16 (1): 11-7
• Fractionated total-body irradiation and high-dose etoposide as a preparatory regimen for bone marrow transplantation for 94 patients with chronic myelogenous leukemia in chronic phase. Snyder DS, Negrin RS, O'Donnell MR, Chao NJ, Amylon MD, Long GD, Nademanee AP, Stein AS, Parker PM, Smith EP. Blood. 1994; 84 (5): 1672-9
• Role of etoposide (VP-16) in preparatory regimens for patients with leukemia or lymphoma undergoing allogeneic bone marrow transplantation. Blume KG, Long GD, Negrin RS, Chao NJ, Kusnierz-Glaz C, Amylon MD. Bone Marrow Transplant. 1994: 14 Suppl 4 S9-10
• Busulfan/etoposide--initial experience with a new preparatory regimen for autologous bone marrow transplantation in patients with acute nonlymphoblastic leukemia. Chao NJ, Stein AS, Long GD, Negrin RS, Amylon MD, Wong RM, Forman SJ, Blume KG. Blood. 1993; 81 (2): 319-23
• Clinical features and outcome of T-cell acute lymphoblastic leukemia in childhood with respect to alterations at the TAL1 locus: a Pediatric Oncology Group study. Bash RO, Crist WM, Shuster JJ, Link MP, Amylon M, Pullen J, Carroll AJ, Buchanan GR, Smith RG, Baer R. Blood. 1993; 81 (8): 2110-7
• Cyclosporine, methotrexate, and prednisone compared with cyclosporine and prednisone for prophylaxis of acute graft-versus-host disease. Chao NJ, Schmidt GM, Niland JC, Amylon MD, Dagis AC, Long GD, Nademanee AP, Negrin RS, O'Donnell MR, Parker PM. N Engl J Med. 1993; 329 (17): 1225-30
• Fractionated total body irradiation and high-dose etoposide as a preparatory regimen for bone marrow transplantation for 99 patients with acute leukemia in first complete remission. Snyder DS, Chao NJ, Amylon MD, Taguchi J, Long GD, Negrin RS, Nademanee AP, O'Donnell MR, Schmidt GM, Stein AS. Blood. 1993; 82 (9): 2920-8
• HRX involvement in de novo and secondary leukemias with diverse chromosome 11q23 abnormalities. Hunger SP, Tkachuk DC, Amylon MD, Link MP, Carroll AJ, Welborn JL, Willman CL, Cleary ML. Blood. 1993; 81 (12): 3197-203
• Langerhans' cell histiocytosis presenting with the superior vena cava syndrome: a case report. Mogul M, Hartman G, Donaldson S, Gelb A, Link M, Amylon M, Glader B. Med Pediatr Oncol. 1993; 21 (6): 456-9
• Multifocal leukoencephalitis caused by varicella-zoster virus in a child with leukemia: successful treatment with acyclovir. Carmack MA, Twiss J, Enzmann DR, Amylon MD, Arvin AM. Pediatr Infect Dis J. 1993; 12 (5): 402-6
• t(2;14)(p13;q32): a recurring abnormality in lymphocytic leukemia. A Pediatric Oncology Group study. Watson MS, Land VJ, Carroll AJ, Pullen J, Borowitz MJ, Link MP, Amylon M, Behm FG. Cancer Genet Cytogenet. 1992; 58 (2): 121-4
• Allogeneic bone marrow transplantation as therapy for primary induction failure for patients with acute leukemia. Forman SJ, Schmidt GM, Nademanee AP, Amylon MD, Chao NJ, Fahey JL, Konrad PN, Margolin KA, Niland JC, O'Donnell MR. J Clin Oncol. 1991; 9 (9): 1570-4
• Allogeneic bone marrow transplantation for high-risk acute lymphoblastic leukemia during first complete remission. Chao NJ, Forman SJ, Schmidt GM, Snyder DS, Amylon MD, Konrad PN, Nademanee AP, O'Donnell MR, Parker PM, Stein AS. Blood. 1991; 78 (8): 1923-7
• Dermatoglyphics and acute lymphocytic leukemia in children. Edelstein J, Amylon M, Walsh JA. J Pediatr Oncol Nurs. 1991; 8 (1): 30-8
• Lack of transmission of the live attenuated varicella vaccine virus to immunocompromised children after immunization of their siblings. Diaz PS, Au D, Smith S, Amylon M, Link M, Smith S, Arvin AM. Pediatrics. 1991; 87 (2): 166-70
• Philadelphia chromosome and monosomy 7 in childhood acute lymphoblastic leukemia: a Pediatric Oncology Group study. Russo C, Carroll A, Kohler S, Borowitz M, Amylon M, Homans A, Kedar A, Shuster J, Land V, Crist W. Blood. 1991; 77 (5): 1050-6
• Bone marrow transplantation for hematologic malignancies: the Stanford experience. Chao NJ, Amylon MD, Long GD, Negrin RS, Hoppe RT, Horning SJ, Blume KG. Clin Transpl. 1990: 157-63
• Repopulation of marrow after transplantation: MR imaging with pathologic correlation. Stevens SK, Moore SG, Amylon MD. Radiology. 1990; 175 (1): 213-8
• The t(1;14)(p34;q11) is nonrandom and restricted to T-cell acute lymphoblastic leukemia: a Pediatric Oncology Group study. Carroll AJ, Crist WM, Link MP, Amylon MD, Pullen DJ, Ragab AH, Buchanan GR, Wimmer RS, Vietti TJ. Blood. 1990; 76 (6): 1220-4
• Treatment of T-lineage acute lymphoblastic leukemia. Amylon MD, Hematol Oncol Clin North Am. 1990; 4 (5): 937-49
• Reduced neutrophil counts in children with transient erythroblastopenia of childhood. Rogers ZR, Bergstrom SK, Amylon MD, Buchanan GR, Glader BE. J Pediatr. 1989; 115 (5 Pt 1): 746-8
• After treatment ends: psychosocial sequelae in pediatric cancer survivors. Fritz GK, Williams JR, Amylon M. Am J Orthopsychiatry. 1988; 58 (4): 552-61
• Clinical and biologic characterization of T-cell neoplasias with rearrangements of chromosome 7 band q34. Smith SD, Morgan R, Gemmell R, Amylon MD, Link MP, Linker C, Hecht BK, Warnke R, Glader BE, Hecht F. Blood. 1988; 71 (2): 395-402
• Idiotype as a tumor-specific marker in childhood B cell acute lymphoblastic leukemia. Carroll WL, Link MP, Cleary ML, Bologna S, Carswell C, Amylon MD, Smith SD, Levy R. Blood. 1988; 71 (4): 1068-73
• Establishment and characterization of a common acute lymphoblastic leukemia cell line with a deletion of chromosome 3 band q26. Smith SD, Morgan R, Galili N, Amylon MD, Link MP, Hecht F, Sklar J, Glader BE. Cancer Res. 1987; 47 (6): 1652-6
• Chromosome 9 abnormalities in childhood T-cell leukemia. Smith SD, Link MP, Trela M, Amylon M, Sklar J, Morgan R, Hecht F. N Engl J Med. 1986; 315 (3): 195-6
• Intensive retreatment of childhood acute lymphoblastic leukemia in first bone marrow relapse. A Pediatric Oncology Group Study. Rivera GK, Buchanan G, Boyett JM, Camitta B, Ochs J, Kalwinsky D, Amylon M, Vietti TJ, Crist WM. N Engl J Med. 1986; 315 (5): 273-8
• Prednisone stimulation of erythropoiesis in leukemic children during remission. Amylon MD, Perrine SP, Glader BE. Am J Hematol. 1986; 23 (2): 179-81
• Comparison of varicella zoster antibody titers in patients given intravenous immune serum globulin or varicella zoster immune globulin. Paryani SG, Arvin AM, Koropchak CM, Dobkin MB, Wittek AE, Amylon MD, Budinger MD. J Pediatr. 1984; 105 (2): 200-5
• Immune thrombocytopenia associated with acute nonlymphocytic leukemia. Amylon MD, Link MP, Glader BE. J Pediatr. 1984; 105 (5): 776-8
• Varicella zoster antibody titers after the administration of intravenous immune serum globulin or varicella zoster immune globulin. Paryani SG, Arvin AM, Koropchak CM, Wittek AE, Amylon MD, Dobkin MB, Budinger MD. Am J Med. 1984; 76 (3A): 124-7
• A single monoclonal antibody identifies T-cell lineage of childhood lymphoid malignancies. Link M, Warnke R, Finlay J, Amylon M, Miller R, Dilley J, Levy R. Blood. 1983; 62 (4): 722-8
• Cranial nerve involvement in children with leukemia and lymphoma. Paryani SB, Donaldson SS, Amylon MD, Link MP. J Clin Oncol. 1983; 1 (9): 542-5